Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0990
-0.0020 (-1.98%)
At close: Mar 10, 2026

Tianda Pharmaceuticals Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Mar '22 Mar '21 2020 - 2016
Market Capitalization
213363469871501434
Upgrade
Market Cap Growth
-46.49%-22.48%-46.17%73.82%15.35%26.25%
Upgrade
Enterprise Value
250358380787493311
Upgrade
Last Close Price
0.100.170.210.390.210.18
Upgrade
Forward PE
-6.556.556.556.556.55
Upgrade
PS Ratio
0.691.100.881.590.980.92
Upgrade
PB Ratio
0.440.720.791.330.640.55
Upgrade
P/TBV Ratio
0.640.940.951.640.790.69
Upgrade
P/FCF Ratio
9.21--12.69--
Upgrade
P/OCF Ratio
4.80--8.55--
Upgrade
EV/Sales Ratio
0.801.090.711.440.970.66
Upgrade
EV/FCF Ratio
10.80--11.47--
Upgrade
Debt / Equity Ratio
0.280.250.190.220.200.18
Upgrade
Debt / EBITDA Ratio
--20.85---
Upgrade
Debt / FCF Ratio
5.86--2.06--
Upgrade
Net Debt / Equity Ratio
0.080.07-0.10-0.34-0.24-0.12
Upgrade
Net Debt / EBITDA Ratio
-1.21-1.4660.108.046.464.44
Upgrade
Net Debt / FCF Ratio
1.61-1.170.58-3.273.090.50
Upgrade
Asset Turnover
0.390.390.53-0.440.46
Upgrade
Inventory Turnover
2.843.384.88-3.863.82
Upgrade
Quick Ratio
0.680.690.891.401.831.80
Upgrade
Current Ratio
0.910.861.101.542.132.83
Upgrade
Return on Equity (ROE)
-13.15%-11.19%-4.01%--2.74%-3.34%
Upgrade
Return on Assets (ROA)
-4.85%-4.02%-1.81%--2.40%-2.08%
Upgrade
Return on Invested Capital (ROIC)
-11.72%-10.06%-6.02%-13.65%-6.81%-5.88%
Upgrade
Return on Capital Employed (ROCE)
-11.30%-10.50%-4.80%-9.70%-4.90%-3.70%
Upgrade
Earnings Yield
-31.65%-16.89%-5.15%-6.27%-3.95%-6.25%
Upgrade
FCF Yield
10.86%-8.34%-21.13%7.88%-12.37%-42.21%
Upgrade
Dividend Yield
--1.22%0.89%1.21%1.42%
Upgrade
Total Shareholder Return
--1.22%0.89%1.21%1.42%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.